2 completed. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow ReProtect Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contraceptive Effectiveness and Safety of the SILCS Diaphragm SILCS Diaphragm, Nonoxynol-9 Gel, Buffer Gel - Contraception | Phase 2 / Phase 3 | Completed | CONRAD | 450 | 2008-01-01 | 2018-03-16 |
| Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm Drug: BufferGel® with diaphragm - Contraception | Phase 2 / Phase 3 | Completed | ReProtect Inc | 200 | 2004-01-01 | 2006-11-09 |
BufferGel (1) · Contraceptive Devices, Female (1)
United States (1)
Alfred Poindexter, MD (1) · David Archer, MD (1) · Kurt Barnhart, MD (1) · Lynn Bradley, M.Sc. (1) · Mitch M Creinin, MD (1) · Ron Frezieres, MSPH (1)